30
/de/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
June 15, 2024
2162554
179119
2

1 Jan 2016 Jahr - Pembrolizumab extends NSCLC survival, with fewer side effects

Beschreibung:

Pembrolizumab improves survival and causes fewer side effects than standard chemotherapy for patients.

Zugefügt zum Band der Zeit:

16 Nov 2018
0
0
264

Datum:

1 Jan 2016 Jahr
Jetzt
~ 8 years and 5 months ago